Lorraine Portelance MD FASTRO
Gastrointestinal Cancer, Gynecologic Cancer
Vice Chair/Clinic Division Chief
Join to View Full Profile
12902 USF Magnolia DrTampa, FL 33612
Phone+1 786-266-2811
Dr. Portelance is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Lorraine Portelance, MD, is a Radiation Oncologist located in Tampa, FL, serving as the Vice Chair/Clinical Division Chief at Moffitt Comprehensive Cancer Center. She graduated from the University of Montreal Faculty of Medicine in 1997. Dr. Portelance has expertise in on-board adaptive therapy, brachytherapy, endometrial cervical and lower GI neoplasms. Her academic contributions include multiple publications focused on advanced radiation therapy techniques and cancer treatment guidelines. She has been the Principal Investigator in several clinical trials, and her work has been recognized with honors, such as being named a Regional Top Doctor by Castle Connolly in 2014 and American Society of Radiation Oncology Fellow in 2017.
Education & Training
University of Montreal Faculty of MedicineClass of 1997
Certifications & Licensure
FL State Medical License 2010 - 2028
American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Inpatient 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification OpTime Surgical 2014 Certified Module, Epic Systems Corporation, 2014-2017
Clinical Trials
- Gemcitabine Hydrochloride With or Without Erlotinib Hydrochloride Followed by the Same Chemotherapy Regimen With or Without Radiation Therapy and Capecitabine or Fluorouracil in Treating Patients With Pancreatic Cancer That Has Been Removed by Surgery Start of enrollment: 2010 Apr 05
- MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer Start of enrollment: 2011 Dec 27
- Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial Start of enrollment: 2011 Oct 31
Publications & Presentations
PubMed
- Pelvic chemoradiation with high-dose-rate brachytherapy boost for synchronous prostate and rectal cancers: A rare case series and treatment framework.Aren Singh Saini, Ritesh Kumar, Isabella Bustillos, Aditya Garg, John Peterson
Brachytherapy. 2026-05-07 - Executive Summary of the American Radium Society (ARS) Appropriate Use Criteria (AUC) for Management of Locally Advanced Endometrial Cancer.Mary McGunigal, Tracy Sherertz, Fernanda Musa, Parul Barry, Idalid Franco
Practical Radiation Oncology. 2026-01-16 - Novel Use of Bland Trans-Arterial Embolization for Hepatoblastoma: A Case Report.Dan Pham, Armando Vera, Chong Bin He, Rachel S Kronenfeld, Alyson Trillo
Pediatric Transplantation. 2025-08-01
Press Mentions
The Future of Radiation Is on Her Mind, but the Patients Are in Her HeartOctober 16th, 2025
ASTRO to Feature ViewRay's MRIdianSeptember 10th, 2019
Technology Aiding the Fight Against Cancer’s TumorsMay 25th, 2016
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
